Floatz logo

7 assets in Disease

Therapeutic assets addressing Disease, rated under Floatz methodology v0.2 and sorted by current rating.

AssetSponsorPhaseRating
(±)-2-(O-Chlorophenyl)-2-(Methylamino)Cyclohexanone
Disease
RIVER FoundationP4BB (67)
Retigabine
Disease
Xenon Pharmaceuticals Inc.P3CCC (54)
Ipilimumab
Disease
H. Lee Moffitt Cancer Center and Research InstituteP2CCC (53)
Nivolumab
Disease
H. Lee Moffitt Cancer Center and Research InstituteP2CCC (53)
Minocycline
Disease
Joyce ChenP2/3NR ()